Seeking Alpha

Nektar Therapeutics (NKTR +6.7%) gets a lift after saying it will present positive...

Nektar Therapeutics (NKTR +6.7%) gets a lift after saying it will present positive proof-of-concept data from its first Phase 1 clinical trial of NKTR-181 at the American Academy of Pain Management's 22nd Annual Clinical Meeting.
Comments (1)
  • Vitor_B
    , contributor
    Comments (9) | Send Message
     
    Good, I'm long NKTR.
    21 Sep 2011, 01:13 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector